Citation: E. Rabizadeh et al., MODULATION OF HEMATOPOIETIC GROWTH-FACTOR SECRETION FROM HUMAN MONONUCLEAR-CELLS BY A NOVEL BUTYRIC-ACID DERIVATIVE, European cytokine network, 9(3), 1998, pp. 64-64
Authors:
GOFERDADOSH N
KLEPFISH A
SCHMILOWITZ H
SHAKLAI M
LAHAV J
Citation: N. Goferdadosh et al., COLLAGEN-BINDING INDUCES CHANGES IN ITS PLATELET INTEGRIN RECEPTOR ALPHA(2)BETA(1), Platelets, 9(3-4), 1998, pp. 197-201
Authors:
OFFEN D
ACHIRON A
WASSERMAN L
MILLER M
SHAKLAI M
DABBY R
GORODIN S
SHOHAT B
Citation: D. Offen et al., HTLV-1 IN MOUTHWASH CELLS FROM A TSP HAM PATIENT AND ASYMPTOMATIC CARRIERS/, Archives of virology, 143(5), 1998, pp. 1029-1034
Authors:
AVIRAM A
BLICKSTEIN D
LUBOSHITZ J
STARK P
BAIREY O
PROKOCIMER M
MAGEN H
SHAKLAI M
Citation: A. Aviram et al., BCR-ABL TRANSCRIPTS IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE DISORDERS, Experimental hematology, 26(8), 1998, pp. 423-423
Authors:
MILLER R
ACHIRON A
SHAKLAI M
STARK P
MAAYAN S
HANNIG H
HUNSMANN G
BODEMER W
SHOHAT B
Citation: R. Miller et al., ETHNIC CLUSTER OF HTLV-I INFECTION IN ISRAEL AMONG THE MASHHADI JEWISH POPULATION, Journal of medical virology, 56(3), 1998, pp. 269-274
Citation: O. Bairey et al., SEVERE TISSUE NECROSIS AFTER CISPLATIN EXTRAVASATION AT LOW CONCENTRATION - POSSIBLE IMMEDIATE RECALL PHENOMENON, Journal of the National Cancer Institute, 89(16), 1997, pp. 1233-1234
Citation: O. Gohar et al., DIFFERENTIATION-INDUCED CHANGES IN THE EXPRESSION OF THROMBOSPONDIN-1AND ITS RECEPTORS IN TUMOR-CELLS OF HEMATOPOIETIC ORIGIN, Thrombosis and haemostasis, 1997, pp. 2255-2255
Authors:
GOFFERDADOSH N
KLEPFISH A
SCHMILOWITZ H
SHAKLAI M
LAHAV J
Citation: N. Gofferdadosh et al., AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING, Thrombosis and haemostasis, 1997, pp. 2750-2750
Authors:
BAIREY O
GABBAY U
BLICKSTEIN D
STARK P
PROKOCIMER M
EPSTEIN O
SHAKLAI M
LAHAV J
Citation: O. Bairey et al., LEVELS OF PROTEIN-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRST-LINE CHEMOTHERAPY IN LYMPHOMA PATIENTS, Hematological oncology, 15(3), 1997, pp. 121-127
Authors:
AVIRAM A
REPHAELI A
SHAKLAI M
NUDELMAN A
BENDROR I
MARON L
RABIZADEH E
Citation: A. Aviram et al., EFFECT OF THE CYTOSTATIC BUTYRIC-ACID PRO-DRUG, PIVALOYLOXYMETHYL BUTYRATE, ON THE TUMORIGENICITY OF CANCER-CELLS, Journal of cancer research and clinical oncology, 123(5), 1997, pp. 267-271
Authors:
ZIMRA Y
WASSERMAN L
MARON L
SHAKLAI M
NUDELMAN A
REPHAELI A
Citation: Y. Zimra et al., BUTYRIC-ACID AND PIVALOYLOXYMETHYL BUTYRATE, AN-9, A NOVEL BUTYRIC-ACID DERIVATIVE, INDUCE APOPTOSIS IN HL-60 CELLS, Journal of cancer research and clinical oncology, 123(3), 1997, pp. 152-160
Authors:
BLICKSTEIN D
AVIRAM A
LUBOSHITZ J
PROKOCIMER M
STARK P
BAIREY O
SULKES J
SHAKLAI M
Citation: D. Blickstein et al., BCR-ABL TRANSCRIPTS IN BONE-MARROW ASPIRATES OF PHILADELPHIA-NEGATIVEESSENTIAL THROMBOCYTHEMIA PATIENTS - CLINICAL PRESENTATION, Blood, 90(7), 1997, pp. 2768-2771
Authors:
BAIREY O
ZIMRA Y
SHAKLAI M
OKON E
RABIZADEH E
Citation: O. Bairey et al., EXPRESSION OF BCL-2, BAX AND BAK PROTEINS IN SHORT AND LONG-LIVED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMAS, Blood, 90(10), 1997, pp. 3870-3870
Authors:
BAIREY O
STARK P
BLICKSTEIN D
PROKOCIMER M
LUBOSHITZ J
SHAKLAI M
Citation: O. Bairey et al., STAGE II(S) CHRONIC LYMPHOCYTIC-LEUKEMIA - A DISTINCT ENTITY WITH A FAVORABLE CLINICAL COURSE, Blood, 90(10), 1997, pp. 4074-4074
Authors:
BAIREY O
GABBAY U
BLICKSTEIN D
STARK P
PROKOCIMER M
EPSTEIN O
SHAKLAI M
LAHAV J
Citation: O. Bairey et al., LEVELS OF PROTEINS-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRSTLINE CHEMOTHERAPY IN LYMPHOMA PATIENTS, Blood, 90(10), 1997, pp. 349-349
Authors:
GOFERDADOSH N
KLEPFISH A
SCHMILOWITZ H
SHAKLAI M
LAHAV J
Citation: N. Goferdadosh et al., AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING, Biochemical and biophysical research communications, 232(3), 1997, pp. 724-727
Authors:
RABIZADEH E
SHAKLAI M
EISENBACH L
NUDELMAN A
REPHAELI A
Citation: E. Rabizadeh et al., ESTERASE INHIBITORS DIMINISH THE MODULATION OF GENE-EXPRESSION BY BUTYRIC-ACID DERIVATIVE, PIVALOYLOXYMETHYL BUTYRATE (AN-9), Israel journal of medical sciences, 32(12), 1996, pp. 1186-1191
Authors:
SHAKLAI S
BAIREY O
BLICKSTEIN D
PROKOCIMER M
HADAR H
LAHAV M
SULKES J
SHAKLAI M
Citation: S. Shaklai et al., SEVERE MYELOTOXICITY OF ORAL ETOPOSIDE IN HEAVILY PRETREATED PATIENTSWITH NON-HODGKINS-LYMPHOMA OR CHRONIC LYMPHATIC-LEUKEMIA, Cancer, 77(11), 1996, pp. 2313-2317
Authors:
BLICKSTEIN D
AVIRAM A
LUBOSHITZ J
PROKOCIMER M
STARK P
BAIREY O
SULKES J
SHAKLAI M
Citation: D. Blickstein et al., BCR-ABL TRANSCRIPTS IN BONE-MARROW ASPIRATES OF PH-NEGATIVE ESSENTIALTHROMBOCYTHEMIA PATIENTS - CLINICAL PRESENTATION, Blood, 88(10), 1996, pp. 3539-3539
Authors:
SHOHAT B
MILLER M
ACHIRON A
DJALDETTI R
SHAKLAI M
Citation: B. Shohat et al., DETECTION OF PROVIRAL HUMAN-T-LYMPHOTROPIC-VIRUS TYPE-I (HTLV-1) DNA AND ANTIBODIES TO HTLV-1 IN SALIVA OF PERSONS AT RISK OF HTLV-1 INFECTION IN ISRAEL, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 202-202
Authors:
MILLER M
ACHIRON A
STARK B
SHAKLAI M
SHOHAT B
Citation: M. Miller et al., A SURVEY OF HTLV-1 ANTIBODIES AMONG 1292 ISRAELI PEOPLE, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 207-207
Authors:
SHOHAT B
MILLER M
ACHIRON A
HANNIG H
HUNSMANN G
BODEMER W
SHAKLAI M
Citation: B. Shohat et al., TRANSMISSION OF HTLV-1 TO RATS VIA BLOOD-LYMPHOCYTES AND VIA MOUTHWASH CELLS FROM SEROPOSITIVE HEALTHY CARRIERS AND HTLV-1-ASSOCIATED SPASTIC PARAPARESIS PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 229-229
Authors:
INBAL A
AVISSAR N
SHAKLAI M
KURITZKY A
SCHEJTER A
BENDAVID E
SHANSKE S
GARTY BZ
Citation: A. Inbal et al., MYOPATHY, LACTIC-ACIDOSIS, AND SIDEROBLASTIC ANEMIA - A NEW SYNDROME, American journal of medical genetics, 55(3), 1995, pp. 372-378
Authors:
LAHAV M
LUBOSHITZ Y
SHIPERKRAVITZ M
SHEMTOV N
STRAHILEVITZ J
SHAKLAI M
Citation: M. Lahav et al., EVALUATION OF BONE-MARROW RESERVE BY A SINGLE GM-CSF ADMINISTRATION PRIOR TO CHOP CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 2781-2781